Lepu Biotech
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lepu Biotech - overview
Established
2018
Location
Shanghai, Shanghai, China
Primary Industry
Pharmaceuticals
About
Established in 2018 and based in Shanghai, China, Lepu Biotech operates as a biopharmaceutical company focusing on the field of tumor treatment. The company has developed a pipeline of multiple oncology products, including eight clinical-stage candidates, three preclinical candidates and three clinical-stage candidates. Its pipeline covers the main nodes of the tumor immune cycle, such as immune desert tumors and inflammatory tumors.
Current Investors
Shiyu Capital, Kaiyuan Guochuang Asset Management, Sumin Investment
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development, Specialty Pharmaceuticals
Company Stage
Mature
Total Amount Raised
Subscriber access only
Lepu Biotech - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman of the Board, Chief Executive Officer, and Founder | BM | ||||||
| Chairman of the Board, Chief Executive Officer, and Founder | BM | ||||||
| Chief Executive Officer & General Manager | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.